Edgestream Partners L.P. Buys 10,169 Shares of Ingevity Corporation $NGVT

Edgestream Partners L.P. increased its stake in shares of Ingevity Corporation (NYSE:NGVT) by 11.3% during the first quarter, according to its most recent filing with the SEC. The institutional investor owned 100,487 shares of the company’s stock after purchasing an additional 10,169 shares during the period. Edgestream Partners L.P.’s holdings in Ingevity were worth $7,158,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in the stock. Los Angeles Capital Management LLC raised its stake in shares of Ingevity by 94.2% during the 4th quarter. Los Angeles Capital Management LLC now owns 30,877 shares of the company’s stock worth $1,827,000 after acquiring an additional 14,975 shares in the last quarter. Allspring Global Investments Holdings LLC acquired a new stake in Ingevity in the fourth quarter valued at approximately $8,083,000. Pacer Advisors Inc. purchased a new position in Ingevity in the fourth quarter worth $9,660,000. Principal Financial Group Inc. grew its holdings in Ingevity by 269.9% in the fourth quarter. Principal Financial Group Inc. now owns 652,237 shares of the company’s stock worth $38,599,000 after purchasing an additional 475,907 shares during the last quarter. Finally, Bessemer Group Inc. increased its position in shares of Ingevity by 465.9% during the first quarter. Bessemer Group Inc. now owns 314,739 shares of the company’s stock worth $22,419,000 after purchasing an additional 259,124 shares in the last quarter. Institutional investors own 91.59% of the company’s stock.

Ingevity Stock Down 0.8%

NGVT stock opened at $70.02 on Friday. The stock has a market capitalization of $2.43 billion, a PE ratio of 47.63 and a beta of 1.16. Ingevity Corporation has a 52 week low of $39.74 and a 52 week high of $79.29. The company has a quick ratio of 0.92, a current ratio of 1.42 and a debt-to-equity ratio of 27.83. The firm has a 50 day moving average of $71.63 and a 200 day moving average of $70.95.

Ingevity (NYSE:NGVT) last issued its quarterly earnings results on Wednesday, July 29th. The company reported $1.74 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.33 by $0.41. The business had revenue of $314.10 million for the quarter, compared to analyst estimates of $312.20 million. Ingevity had a net margin of 4.65% and a return on equity of 261.97%. Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. Sell-side analysts forecast that Ingevity Corporation will post 5.05 earnings per share for the current year.

Ingevity News Roundup

Here are the key news stories impacting Ingevity this week:

• Positive Sentiment: Quarterly earnings beat expectations. Ingevity reported second-quarter EPS of $1.74, above analyst estimates ranging from $1.31 to $1.33 and up from $1.39 a year earlier. Revenue of $314.1 million also exceeded the $312.2 million consensus estimate. Ingevity Tops Q2 Earnings and Revenue Estimates
• Positive Sentiment: Full-year 2026 adjusted EPS guidance was raised. The company now expects adjusted EPS of $5.00 to $5.45, above the prior outlook and higher than the roughly $4.95-$5.05 analyst consensus range. Ingevity also increased its full-year adjusted EBITDA outlook following a solid start to the year. Ingevity’s Q2 Adjusted Earnings Increase, Net Sales Decline; 2026 Adjusted EPS Outlook Raised
• Neutral Sentiment: Revenue guidance remains broadly in line with expectations. Ingevity maintained 2026 revenue guidance of approximately $1.1 billion to $1.2 billion, compared with consensus expectations near $1.1 billion. Ingevity Reports Second Quarter 2026 Financial Results
• Negative Sentiment: Net sales declined year over year. Although quarterly revenue edged past estimates, the year-over-year sales decline creates concern about underlying demand and may offset some of the benefit from stronger earnings guidance. The company also reported a negative net margin, adding to investor caution.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on NGVT. Wall Street Zen upgraded Ingevity from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, July 7th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Ingevity in a research note on Friday, July 17th. Two investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Ingevity has an average rating of “Hold” and an average target price of $80.00.

Insider Activity

In related news, SVP Terrance M. Dyer sold 496 shares of the company’s stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $68.49, for a total value of $33,971.04. Following the transaction, the senior vice president directly owned 7,202 shares of the company’s stock, valued at $493,264.98. This represents a 6.44% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.88% of the stock is currently owned by insiders.

Ingevity Profile

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.